MYC and B-cell non-Hodgkin lymphoma: To investigate the role of miR-17-19b in full-blown B cell lymphomas, we perturbed the system by increasing the expression of the cluster in λ-MYC lymphoma B cells, whose endogenous miR-17-19b levels are comparable to those of human BL (Fig. 1a, right panel).